You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
復星醫藥(02196.HK)子公司擬3.9億港元受讓復鋭醫療科技21.93%股權持股升至74.76%
格隆匯 09-30 16:50

格隆匯9月30日丨復星醫藥(02196.HK)公佈,2019年9月30日,本公司控股子公司Ample Up Limited(即能悦有限公司)與關聯方Magnificent View簽訂《SharePurchase Agreement》,Ample Up擬以4.02港元/股受讓Magnificent View持有的Sisram(復鋭醫療科技)9697.6萬股股份(約佔Sisram截至本公告日已發行股份總數的21.93%),本次交易對價的總額約為3.9億港元。

該等每股轉讓價格較Sisram於2019年9月27日(即《股份轉讓協議》簽訂前最後一個交易日)的收市價4.11港元/股、《股份轉讓協議》簽署之日前十個交易日的平均收市價4.13港元/股分別折讓約2.20%、約2.60%。

本次交易完成後,本集團將合計持有Sisram3.3億股股份,約佔其截至本公告日已發行股份總數的74.76%;Sisram仍為本公司控股子公司。

公司稱,Ample Up擬以自籌資金支付本次交易的對價。作為本集團醫療器械研發和製造重要平台之一,本次交易將有利於本集團更好地支持Sisram在醫療技術領域的佈局和發展。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account